DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Anupam Rasayan India Limited — Board Meeting Intimation

NSE 1 hr ago·3 Nov 2026, 6:17 pm

Anupam Rasayan India

Anupam Rasayan India Limited has announced that its board will meet on November 6, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026. This interim reporting is a standard corporate procedure for listed entities.

For investors, this update is a key milestone as it provides an early look into the company's operational performance and financial health before the full-year results are released. It offers a chance to assess the company's growth trajectory and efficiency in the interim period.

Investors should watch for the specific details on revenue growth, margins, and cash flow in the unaudited report. This data will be crucial for evaluating the company's current standing and future prospects in the specialty chemicals sector.